Your browser doesn't support javascript.
loading
Plasma Phosphorylated Tau 231 Increases at One-Year Intervals in Cognitively Unimpaired Subjects.
Martínez-Dubarbie, Francisco; López-García, Sara; Lage, Carmen; Di Molfetta, Guglielmo; Fernández-Matarrubia, Marta; Pozueta-Cantudo, Ana; García-Martínez, María; Corrales-Pardo, Andrea; Bravo, María; Jiménez-Bonilla, Julio; Quirce, Remedios; Marco de Lucas, Enrique; Drake-Pérez, Marta; Tordesillas, Diana; López-Hoyos, Marcos; Irure-Ventura, Juan; Valeriano-Lorenzo, Elizabeth; Blennow, Kaj; Ashton, Nicholas J; Zetterberg, Henrik; Rodríguez-Rodríguez, Eloy; Sánchez-Juan, Pascual.
Afiliação
  • Martínez-Dubarbie F; Neurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.
  • López-García S; Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain.
  • Lage C; Neurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.
  • Di Molfetta G; Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain.
  • Fernández-Matarrubia M; Neurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.
  • Pozueta-Cantudo A; Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain.
  • García-Martínez M; Atlantic Fellow for Equity in Brain health, Global Brain Health Institute, University of California, San Francisco, CA, USA.
  • Corrales-Pardo A; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
  • Bravo M; Neurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.
  • Jiménez-Bonilla J; Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain.
  • Quirce R; Neurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.
  • Marco de Lucas E; Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain.
  • Drake-Pérez M; Neurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.
  • Tordesillas D; Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain.
  • López-Hoyos M; Neurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.
  • Irure-Ventura J; Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain.
  • Valeriano-Lorenzo E; Neurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.
  • Blennow K; Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain.
  • Ashton NJ; Nuclear Medicine Department, Marqués de Valdecilla University Hospital, University of Cantabria and Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain.
  • Zetterberg H; Nuclear Medicine Department, Marqués de Valdecilla University Hospital, University of Cantabria and Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain.
  • Rodríguez-Rodríguez E; Radiology Department, Marqués de Valdecilla University Hospital, Santander, Spain.
  • Sánchez-Juan P; Radiology Department, Marqués de Valdecilla University Hospital, Santander, Spain.
J Alzheimers Dis ; 98(3): 1029-1042, 2024.
Article em En | MEDLINE | ID: mdl-38489191
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article